PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Palonosetron with netupitant - Nausea and vomiting (chemotherapy induced)
PAD Profile : Palonosetron with netupitant - Nausea and vomiting (chemotherapy induced)
Keywords :
Netupitant and palonosetron, emetogenic chemotherapy
Brand Names Include :
Akynzeo
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Nabilone
- Cyclizine hydrochloride
- Dexamethasone
- Domperidone
- Metoclopramide hydrochloride
- Ondansetron hydrochloride
- Olanzapine
- Haloperidol
- Prochlorperazine maleate
- Aprepitant
- Fosaprepitant
- Levomepromazine hydrochloride
- Granisetron
- Palonosetron hydrochloride
- Netupitant/palonosetron hydrochloride
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
14 September 2015
Not Set
This drug has not yet been evaluated by NICE or the Surrey and Sussex Prescribing Clinical Network (PCN). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing.
The PCN will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team if you wish to make a submission.
Associated BNF Codes
04. Central Nervous System
04.06.00. Drugs used in nausea and vertigo